HealthStream (HSTM)
(Delayed Data from NSDQ)
$28.67 USD
-0.44 (-1.51%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $28.72 +0.05 (0.17%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Income Statements
Fiscal Year end for HealthStream, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 279 | 267 | 257 | 245 | 254 |
Cost Of Goods | 95 | 91 | 91 | 89 | 104 |
Gross Profit | 184 | 176 | 166 | 155 | 150 |
Selling & Adminstrative & Depr. & Amort Expenses | 168 | 163 | 158 | 140 | 136 |
Income After Depreciation & Amortization | 16 | 12 | 8 | 16 | 15 |
Non-Operating Income | 2 | 3 | 0 | 2 | 3 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 19 | 16 | 8 | 18 | 18 |
Income Taxes | 3 | 3 | 2 | 4 | 4 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 15 | 12 | 6 | 14 | 14 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 2 |
Net Income (GAAP) | 15 | 12 | 6 | 14 | 16 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 69 | 61 | 54 | 55 | 51 |
Depreciation & Amortization (Cash Flow) | 53 | 49 | 46 | 39 | 36 |
Income After Depreciation & Amortization | 16 | 12 | 8 | 16 | 15 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 30.67 | 30.72 | 31.62 | 31.99 | 32.43 |
Diluted EPS Before Non-Recurring Items | 0.50 | 0.39 | 0.24 | 0.36 | 0.44 |
Diluted Net EPS (GAAP) | 0.50 | 0.39 | 0.18 | 0.44 | 0.49 |
Fiscal Year end for HealthStream, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 71.56 | 72.76 | 70.58 | 70.34 | 69.20 |
Cost Of Goods | 23.74 | 24.62 | 24.01 | 23.59 | 23.57 |
Gross Profit | 47.82 | 48.14 | 46.57 | 46.75 | 45.63 |
SG&A, R&D, and Dept/Amort Expenses | 43.41 | 42.46 | 42.32 | 41.89 | 41.62 |
Income After SG&A, R&D, and Dept/Amort Expenses | 4.41 | 5.68 | 4.25 | 4.86 | 4.01 |
Non-Operating Income | 0.89 | 0.85 | 1.16 | 0.59 | 0.49 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 5.30 | 6.54 | 5.42 | 5.45 | 4.50 |
Income Taxes | 1.13 | 1.32 | 0.83 | 1.59 | 0.37 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 4.17 | 5.23 | 4.59 | 3.87 | 4.13 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 4.17 | 5.23 | 4.59 | 3.87 | 4.13 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 30.53 | 30.42 | 30.49 | 30.77 | 30.78 |
Diluted EPS Before Non-Recurring Items | 0.14 | 0.17 | 0.15 | 0.13 | 0.13 |
Diluted Net EPS (GAAP) | 0.14 | 0.17 | 0.15 | 0.13 | 0.13 |